BEUDAMED
    FDA Adverse Event Other Summary report: N

    EUFLEXXA

    MDR report key: 4834870 · Received June 4, 2015

    Report

    Report Number
    MW5043023
    Event Type
    Other
    Date Received
    June 4, 2015
    Date of Event
    May 5, 2015
    Report Date
    June 4, 2015
    Manufacturer
    FERRING PHARMACEUTICALS
    Product Code
    MOZ
    Report Source
    Voluntary report
    Reporter Location
    PA, US
    Reporter Occupation
    PHARMACIST

    Narratives

    Description of Event or Problem · 1

    PATIENT'S WIFE STATED THAT PATIENT RECEIVED ONLY 1 OUT OF 3 EUFLEXXA INJECTIONS. PATIENT DIDN'T REALIZE THAT HE NEEDED WEEKLY INJECTIONS FOR 3 WEEKS. DOCTOR'S OFFICE DIDN'T SCHEDULE SUBSEQUENT INJECTIONS. PATIENT WILL CONTACT DOCTOR TO SEE HOW HE WANTS TO PROCEED WITH REMAINING 2 INJECTIONS. DR. (B)(6). DOSE: 20MG, ONCE WEEKLY, INTO KNEE. REASON FOR USE : LOC PRIM OSTEOART-L/LEG.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    363623 EUFLEXXA EUFLEXXA, 10 MG/ML MOZ FERRING PHARMACEUTICALS K13899B

    Patients

    Seq Age Sex Outcome Treatment
    1 59 YR